In a significant academic reform with far-reaching implications for healthcare, pharmaceutical research, and public health innovation, the University Grants Commission (UGC) has officially introduced Statistics as a subject in the UGC National Eligibility Test (NET) from June 2026 onward. The decision, announced following expert committee recommendations during the Commission’s 597th meeting, marks a strategic expansion of India’s higher education and research ecosystem.
The inclusion of Statistics is expected to strengthen the national talent pipeline in critical domains such as biostatistics, epidemiology, clinical research, health economics, and pharmaceutical data analytics—fields increasingly essential to evidence-based healthcare systems and drug development. As healthcare becomes more data-driven, this move could empower a new generation of researchers, educators, and analysts capable of advancing disease surveillance, precision medicine, and healthcare policy.
For students aspiring to build careers at the intersection of mathematics, medicine, and life sciences, the update opens broader opportunities in academia and industry alike. Experts believe the addition will not only diversify NET’s academic framework but also support India’s growing role in global health research and innovation.
With this policy shift, UGC signals a future-ready approach to education—one that recognise data science and statistical expertise as foundational to modern healthcare advancement.
